Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39826 - 39850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Etoposide	Approved Investigational	PUS3	83480	downregulated	Etoposide results in decreased expression of PUS3 mRNA	11q24.2	A21499
Etoposide	Approved Investigational	RAD52	5893	upregulated	Etoposide results in increased expression of RAD52 mRNA	12p13.33	A22595
Etoposide	Approved Investigational	RBM34	23029	downregulated	Etoposide results in decreased expression of RBM34 mRNA	1q42.3	A21499
Etoposide	Approved Investigational	RETSAT	54884	upregulated	Etoposide results in increased expression of RETSAT mRNA	2p11.2	A21863
Etoposide	Approved Investigational	RFC1	5981	downregulated	Etoposide results in decreased expression of RFC1 mRNA	4p14	A21499
Etoposide	Approved Investigational	RIPK2	8767	upregulated	Etoposide results in increased expression of RIPK2 mRNA	8q21.3	A21152
Etoposide	Approved Investigational	RIPPLY3	53820	upregulated	Etoposide results in increased expression of RIPPLY3 mRNA	21q22.13	A21863
Etoposide	Approved Investigational	RNF113A	7737	downregulated	Etoposide results in decreased expression of RNF113A mRNA	Xq24	A21499
Etoposide	Approved Investigational	ROBO3	64221	upregulated	Etoposide results in increased expression of ROBO3 mRNA	11q24.2	A21863
Etoposide	Approved Investigational	RRAS	6237	upregulated	Etoposide results in increased expression of RRAS mRNA	19q13.33	A21863
Etoposide	Approved Investigational	RRM2B	50484	upregulated	Etoposide results in increased expression of RRM2B mRNA	8q22.3	A21622
Etoposide	Approved Investigational	SDC1	6382	upregulated	Etoposide results in increased expression of SDC1 mRNA	2p24.1	A20666
Etoposide	Approved Investigational	SDHAF1	644096	downregulated	Etoposide results in decreased expression of SDHAF1 mRNA	19q13.12	A21499
Etoposide	Approved Investigational	SESN1	27244	upregulated	Etoposide results in increased expression of SESN1 mRNA	6q21	A21499
Etoposide	Approved Investigational	SFN	2810	upregulated	Etoposide results in increased expression of SFN mRNA	1p36.11	A21863
Etoposide	Approved Investigational	SLBP	7884	downregulated	Etoposide results in decreased expression of SLBP mRNA	4p16.3	A21499
Etoposide	Approved Investigational	SLC1A5	6510	downregulated	Etoposide results in decreased expression of SLC1A5 mRNA	19q13.32	A21499
Etoposide	Approved Investigational	SLC2A6	11182	upregulated	Etoposide results in increased expression of SLC2A6 mRNA	9q34.2	A21863
Etoposide	Approved Investigational	SPATA18	132671	upregulated	Etoposide results in increased expression of SPATA18 mRNA	4q12	A21863
Etoposide	Approved Investigational	STOM	2040	upregulated	Etoposide results in increased expression of STOM mRNA	9q33.2	A21863
Etoposide	Approved Investigational	TAP1	6890	upregulated	Etoposide results in increased expression of TAP1 mRNA	6p21.32	A20666 A21863
Etoposide	Approved Investigational	TAX1BP3	30851	upregulated	Etoposide results in increased expression of TAX1BP3 mRNA	17p13.2	A20666
Etoposide	Approved Investigational	TFAM	7019	upregulated	Etoposide results in increased expression of TFAM mRNA	10q21.1	A22593
Etoposide	Approved Investigational	TFEC	22797	downregulated	Etoposide results in decreased expression of TFEC mRNA	7q31.2	A21499
Etoposide	Approved Investigational	TGFA	7039	upregulated	Etoposide results in increased expression of TGFA mRNA	2p13.3	A22581

Displaying entries 39826 - 39850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability